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The profile of 247 patients with erythroderma during a 23 year period from January, 1962 through March, 1985, with a
follow-up period ranging from 1 to 26 years were analysed. The patients presented with diffuse erythema, scaling and
pruritus of more than 2 months' duration, and the age ranged from 16 to 60 years. Psoriasis was the most frequent
underlying disease with an estimated frequency of 44.9%, the reaction to the use of drugs appeared in 7.3% of total
cases and association with reticulosis showed a frequency of 4.1%. The cause of the erythroderma could not be
determined in 29.2% of the cases. Sex differences in terms of underlying diseases were not observed. One or more
skin biopsies along with the clinical findings were diagnostic or suggestive of the underlying disease in 63.6% of the
cases. Repeated skin biopsies are recommended as the best method for etiologic diagnosis of erythroderma. At
P=0.05 significance level, masculine/feminine ratio of 2 : 1 was found. The question arises wether causal agent of
erythroderma may not be somehow related to different exposure by sex to environmental antigens.
Dermatitis, exfoliative; epidemiology incidence.
Introduction
Erythroderma is a syndrome characterized by
diffuse erythema, scaling, pruritus and prolonged
course. Systemic manifestations may be present
and prognosis is cause-dependent (Abrahams et
al1; Adam2; Fitzpatrick et al4; Gatti et al6; Helm10;
Nebenzahl et al13; Nicolis & Helwig14; Nigam et
al15; Rook et al17 and Sampaio et al18).
In 1868, Hebra (apud Abrahams et al1 and
Nebenzahl et al13) proposed a classification based
on clinical features: Hebra's pityriasis rubra,
Brock's exfoliative dermatitis, scarlatiniform ery-
thema and epidermal exfoliative dermatitis.
In 1913, Nicolis and Helwig14, after studying
135 patients with erythroderma, proposed a classi-
fication based on etiology: a) use of drug related -
40%; b) previous dermatosis related - 26.8%; c)
mycosis fungoides and lymphoma related -17.8%;
d) internal malignancy - 2.8%; e) miscellaneous
etiology - 0.7%; and f) unknown etiology - 11.9%.
Montgomery12 established another classifica-
tion based on histopathologic findings: a) idio-
pathic or primary; and b) secondary to an underly-
ing dermatosis or reticulosis.
According to Rabello et al.16, the patients with
erythroderma do not show any significant alter-
ation of routine laboratory tests. Montgomery12
stressed usefulness of multiple skin biopsies as a
diagnostic and follow-up method.
Treatment must be directed towards the under-
lying diseases, although general measures should
not be forgotten (Nebenzahl et al)13.
The objective of the present work is to profile
the etiology of erythroderma and to verify if there
was a predominance of the syndrome according
to sex.
Subjects and methods
Two hundred and forty seven patients with ery-
throderma seen at Dermatology Unit of a Hospital
of Clinics located at the city of S. Paulo, Brazil,
from 1962 through 1985, were studied. Diffuse
erythema and scaling accompanied by pruritus
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lasting over two months in duration were used as
diagnostic criteria. The patient's age and place of
origin registered at the first visit were used for
stastistical analysis.
The patients were grouped according to the
clinical diagnosis as seen:
a) Related to previous dermatosis: psoriasis,
eczema, atopic eczema, seborrheic eczema,
lamellar ichthyosis, erythrokeratoderma (sys-
temic and progressive forms), pityriasis rubra
pilaris and Darier's disease;
b) Drug use related: contact eczema, systemic
eruption by drug use and photosensitivity;
c) Reticulosis and leukemia related: lymphoma,
mycosis fungoides and Sézary's syndrome;
d) Miscellaneous: nodular scabies;
f) Unknown etiology: the patients who did not
have a known cause at the last visit.
Light microscopy study of skin biopsies was
done and showed one of the following patterns:
a) Subacute or chronic dermatitis;
b) Subacute or chronic psoriasiform dermatitis;
c) Psoriasis;
d) Vasculitis;
e) Suggestive of lymphoma;
f) Others: lamellar ichthyosis, epidermolytic
hyperkeratosis and Darier's disease, and
g) Dermatopathic lymphadenitis.
The study has been designed as a case study*
(Forattini5 and Leser et al).11 the subject group
was compared to patients with dermatosis without-
erythroderma from the same hospital during the
same time period.
The Special Program for Social Science
(SPSS) was used for the analysis of the data.
In order to compare the ratio between three or
more categories in the contingency tables,
Goodman's8 or Kolmogorov-Smirnoffs (apud
Costa-Neto)3 tests, along with Pearson's chi-
square statistics (Costa-Neto)3 were applied,
respecting the frequency restrictions.
As for the tendency evaluation, adjustment by
the method of minimum square and the regression
line was adopted, and the angular coefficient test
was applied, according to Student's t distribution,
with the necessary adjustments. The comparison
between two angular coefficients, with the same
adjustment, was possible due to Student's t distri-
bution (Costa-Neto)3. The significance level
adopted was P=0.05.
Results
Table 1 shows a greater number of feminine
patients in the group without erythroderma
(tcalc=5.051; c.p. (cut point)=2.131), and a greater
number of masculine patients in the group with
erythroderma (tcalc=0.295; c.p.=2.074), however,
this difference has no statistical significance
(Dmax=0.140;c.p.=0.163).
Although, when patients were sub-divided into
sub-groups of 5 year periods (Table 2), according
to the time of the first visit, a significantly higher
number of masculine patients with erythroderma
was found (Table 2; 1st. 5 year-period:
c2calc=5.156; 2nd. 5 year-period: c2calc=15.751; 3rd.
5 year-period c2calc=10.309; c.p.=3.841).
Table 3 shows no differences by sex among
patients without erythroderma who sought assis-
tance in the outpatient clinic.
* Personal communication of Bruce B. Duncan, D. Rumel, M.I.
Schimidt, 1988.
The patients with erythroderma (Table 4)
showed the following distribution: in the group
of from 0 to 15 years old, there was a predomi-
nance of feminine patients (Goodman G statis-
tics=3.790; c.p.=2.448), and amongst those over
61 years of age, there was a predominance of
masculine patients (Goodman G statistics =
2.571; c.p. = 2.448). The highest number of
patients was found to be in the group of from 16
to 60 years old.
Amongst the masculine group (Table 5), ery-
throderma was more frequent in the group of
from 60 to 69 years old (Goodman G statis-
tics=3.885; c.p.=3.751), while amongst the
female group it was more frequent in the 10 to 19
year age group.
The majority of the patients were born in S.
Paulo state (44.6%), in spite of the fact that the
patients' places of birth have not been recorded in
about 40.0% of the cases (Table 6).
Applying the Goodman's test to Table 7
(Goodman's g2=2.448; c.p.=12.592), no significant
difference was found among the ratio of various
causes, by sex.
A group of men between the 3rd and 6th
decades, inclusive, of life, and of women between
1st and 5th decades, inclusive, with psoriasis, was
identified. Cutaneous eruption caused by the use
of drugs was more frequent between the 2nd and
5th decades in both sexes (Table 8).
Comments
In the literature, there are few notes analyzing
erythroderma under its multiple aspects
(Abrahams et al1, Adam2, Gatti et al6, Gentele et
al7, Hasan & Jansen9, Montgomery12, Nicolis &
Helwig14, Nigam et al15 and Rabello et al).16
Initially, the group of patients with erythroder-
ma and the group of patients with other dermatosis
were compared, in an attempt to find a sampling
bias that might have resulted in a higher number of
masculine patients in the group with erythroderma.
As no difference by sex was found when the
population without erythroderma was studied
(Table 1 and 3), it was concluded that the predom-
inance of masculines in the group with erythroder-
ma was not due to any sampling bias. This result is
in agreement with those of other authors, ranging
from 2: 1 (Adam2) to 11: 1 (Nicolis & Helwig).14
In more than 59.0% of the total cases there had
been a prior manifestation of some dermatosis, of
these cases, 44.9% had had psoriasis, 4.0% reticu-
losis/leukemia, and about 30.0% unknown causes
(Table 7), with no difference among the ratio of
the vaious causes according to sex. Therefore, in
this population, the underlying disease was not
responsible for the difference observed between
the sexes in the group of patients with erythroder-
ma (2 masculine: 1 feminine).
The literature shows that there is a predomi-
nance of some dermatosis as a prior manifestation
in the group of patients with erythroderma
(Abrahams et al1; Adam2; Gatti et al6, Gentele et al7
and Hasan & Jansen).9 In literature, psoriasis is the
most frequent dermatosis (25.0 to 60.0%),
although no sensu strictu comparisons between the
literature and our data could be made, since the
diagnosis and criteria of inclusion varied so much.
This is perhaps the cause of the predominance of
cases of drug reaction in Nicolis & Helwig's
study14 and the great number of cases of reticulosis
in Montgomery's study12.
The frequency of unknown causes with ery-
throderma varied from 8.0% (Montgomery)14 to
55.0% (Rabello),16 against 29.0% in this present
study. It is interesting to note that Montgomery12
had undertaken more skin biopsies than any other
author.
It is not easy to compare the data of cases relat-
ed to the use of drug in the present study with
those recorded in the literature because of the great
number of drugs involved and the difference in the
criteria of inclusion. There are many available
drugs and they vary from one country to another
and from one time to another, as observed by
Nigam et al15. Moreover, some authors consider
any drug used before the appearance of erythro-
derma as the causal agent, whereas others do not
do so when a primary dermatosis is present.
Only 19.4% of the cases gave any information
regarding to the use of drugs prior to the develop-
ment of erythroderma, and even in these cases, no
information about the means of administration or
dosage was available. The history of the use of cor-
ticosteroid just before the manifestation of erythro-
derma raised the question as to a possible cause in
the inadequate treatment of a previous dermatosis.
All six patients involved with agrotoxic prod-
ucts were men (Tables 9 and 10) of from 30 to 60
years old and came from the countryside. In spite
of the small sample, it was asked wether environ-
mental antigens might not be causally related to
erythroderma, and whether the predominance of
masculine patients amongst the group with ery-
throderma could be due to their work-related
exposure to the environmental antigens.
One hundred seventy three skin biopsies (1 to
3 biopsies/patient) were performed. Ninety-eight
biopsies (about 60.0%) were either diagnostic or
suggestive of the underlying diseases, and 75
biopsies (about 40.0%) were non-diagnostic
(Table 11).
The data from this research corroborate the pre-
vious findings of Montgomery's 1933 study12 that
skin biopsies, when performed in sufficient num-
bers, and under appropriate conditions, are still the
best mean of diagnosis and follow-up for patients
with erythroderma. Skin biopsy is specially useful
in the diagnosis or exclusion of an early reticulosis,
since the latter process shows earlier changes in the
skin than in other organs (Montgomery).12
Another biopsy is recommended when a patient
shows a poor therapeutic response and when the
histologic feature is not cleared-up, as may happen
the differential diagnosis of Sézary's erythroderma
versus pre-Sézary's erythroderma, mycosis fun-
goides versus persistent reaction to insect bites, and
nodular scabies versus mycosis fungoides or
Hodgkin's lymphoma (Montgomery).12
In striving for an ideal biopsy, the following
advice from Montgomery12 should always be kept
up in mind: whenever possible, biopsies should be
done on an untreated active area, away from the
abdomen or seborrheic areas.
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Resumo
Foi analisado o perfil de 247 doentes com eritrodermia em um período de 23 anos, de Janeiro de 1962 a março de 1985,
com o período de seguimento variando de 1 a 26 anos. Os doentes se apresentavam com eritema universal,
descamação e prurido com mais de 2 meses de duração e a idade variava de 16 a 60 anos. A psoríase foi a doença
associada mais freqüente, com uma proporção estimada de 44,9%, as reações cutâneas ao uso de drogas contribuíram
com 7,3% do total de casos e a associação com reticuloses mostrou uma proporção de 4,1%. A eritrodermia
permaneceu como de causa desconhecida em 29,2% dos casos. Não foram observadas diferenças entre os sexos no
que diz respeito à doença associada. Um ou mais resultados anátomo patológicos das biópsias de pele, em conjunto
com o quadro clínico, foi diagnóstico ou sugestivo do diagnóstico da doença associada em 63,6% dos casos.
Recomendam-se biópsias de pele seriadas como o melhor método para a elucidação diagnostica da eritrodermia. Ao
nível de significância P=0,05, foi encontrada uma proporção homem/mulher de 2 : 1. Especula-se se o agente causal
da eritrodermia estaria relacionado à exposição diferenciada entre os sexos a antígenos do meio ambiente.
Dermatite esfoliativa, epidemiologia. Incidência.
